Editoriali
Bambini e farmaci: le prospettive regolatorie
e informative
Francesca Rocchi
Agenzia Italiana del Farmaco (AIFA)
Novembre 2007 - pagg. 551
Parole chiave
Classificazione MeSH
Bibliografia
1. Turner S, Longworth A, Nunn AJ, et al. Unlicensed drug use on paediatric
wards. BMJ 1998;316:343-5.
2. Conroy S, McIntyre J, Choonara I. Unlicensed and off label use in neonates. Arch Dis Child Fetal Neonatal Ed 1999;80:F142-5.
3. McIntyre J, Conroy S, Avery A, et al. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 2000;83:498-501.
4. Art. 3 D.Lgs. 17 febbraio 1998, n. 23, convertito, con modificazioni, nella Legge 8 aprile 1998, n. 94.1.
5. Regulation EC No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use. Official Journal of the European Union del 27.12.2006.
2. Conroy S, McIntyre J, Choonara I. Unlicensed and off label use in neonates. Arch Dis Child Fetal Neonatal Ed 1999;80:F142-5.
3. McIntyre J, Conroy S, Avery A, et al. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 2000;83:498-501.
4. Art. 3 D.Lgs. 17 febbraio 1998, n. 23, convertito, con modificazioni, nella Legge 8 aprile 1998, n. 94.1.
5. Regulation EC No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use. Official Journal of the European Union del 27.12.2006.
